OAT - ornithine aminotransferase Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100156865
OAT Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001185141.1 | NP_001172070.1 | ornithine aminotransferase, mitochondrial |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
ornithine aminotransferase, mitochondrial |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(9)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-50896 | Erlotinib | Inhibitor | 99.99% | Yes |
| HY-15592 | Cabotegravir | Inhibitor | 99.92% | Unkown |
| HY-12008 | Erlotinib Hydrochloride | Inhibitor | 99.94% | Yes |
| HY-50896R | Erlotinib (Standard) | Inhibitor | 99.97% | Unkown |
| HY-15258 | Lesinurad | Inhibitor | 99.96% | Unkown |
| HY-15592A | Cabotegravir sodium | Inhibitor | 99.87% | Unkown |
| HY-12008R | Erlotinib Hydrochloride (Standard) | Inhibitor | 99.73% | Unkown |
| HY-15258A | Lesinurad sodium | Inhibitor | 99.97% | Unkown |
| HY-12008A | Erlotinib mesylate | Inhibitor | / | Unkown |
Clinical Phase
Bioactive Molecules
(2)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Phase
|
|---|---|---|---|---|
| HY-111345 | Epaminurad | Inhibitor | 99.75% | Phase 3 |
| HY-16278A | Pradigastat sodium | Inhibitor | / | Phase 3 |
Pre-clinical Phase
Bioactive Molecules
(34)
| Art. -Nr. | Produktname |
Wirkung
|
Reinheit |
Rare Diseases
|
|---|---|---|---|---|
| HY-154021A | 5-Fluoromethylornithine dihydrochloride | Inhibitor | 99.08% | Unkown |
| HY-N3513 | Mulberrin | Inhibitor | 99.94% | Unkown |
| HY-16278 | Pradigastat | Inhibitor | 99.88% | Unkown |
| HY-122009 | Indican | Inhibitor | 99.88% | Unkown |
| HY-B0927 | Hydrastine | Inhibitor | 99.57% | Unkown |
| HY-133825 | Cyazofamid | Inhibitor | 98.15% | Unkown |
| HY-W585842 | Estradiol 3-glucuronide | Substrate | 98.00% | Unkown |
| HY-W002438 | 6-Hydroxyindole | Inhibitor | 99.98% | Unkown |
| HY-126848 | Diclofenac acyl glucuronide | Substrate | 98.34% | Unkown |
| HY-N3504 | Ophiopogonin D' | Modulator | 99.94% | Unkown |
| HY-148682 | 18β-Glycyrrhetyl-3-O-sulfate | Inhibitor | / | Unkown |
| HY-50896S | Erlotinib-d6 | Inhibitor | 99.84% | Unkown |
| HY-N7755 | Estradiol 3-glucuronide sodium | Substrate | 98% | Unkown |
| HY-12008S | Erlotinib-d6 hydrochloride | Inhibitor | 98.13% | Unkown |
| HY-B0396B | Tebipenem pivoxil hydrobromide | Substrate | / | Unkown |
| HY-175645 | NLRP3/URAT1-IN-1 | Inhibitor | / | Unkown |
| HY-50896S1 | Erlotinib-13C6 | Inhibitor | / | Unkown |
| HY-15592S4 | Cabotegravir-d6 | Inhibitor | / | Unkown |
| HY-182542 | SOAT-IN-3 | Inhibitor | / | Unkown |
| HY-D3239 | AF405 NHS Ester | Substrate | / | Unkown |
| HY-W740244 | 4’-Hydroxy Trazodone | / | Unkown | |
| HY-12008S1 | Erlotinib-13C6 hydrochloride | Inhibitor | / | Unkown |
| HY-137846A | PF-05221304 tromethamine | Substrate | / | Unkown |
| HY-184557 | DZ-1-DHA | / | Unkown | |
| HY-16443 | S-4048 | / | Unkown | |
| HY-N12007 | OAT1/3-IN-1 | / | Unkown | |
| HY-N12008 | OAT1/3-IN-2 | / | Unkown | |
| HY-155485 | Abi-DZ-1 | / | Unkown | |
| HY-138142 | Euphol acetate | Inhibitor | / | Unkown |
| HY-50896S2 | Erlotinib-d4 | Inhibitor | / | Unkown |
| HY-50896S3 | Erlotinib-d8 | Inhibitor | / | Unkown |
| HY-15258S1 | Lesinurad-d4 | Inhibitor | / | Unkown |
| HY-111345A | Epaminurad hydrochloride | Inhibitor | / | Unkown |
| HY-180227 | URAT1-IN-15 | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service